DELIVERING INNOVATION. WHERE IT’S NEEDED.

Intersect ENT is defining and delivering novel treatments designed to transform the landscape of ENT care. We apply a focused, evidence-based approach to solve clinical challenges and improve the quality of life for patients.

PROPEL Contour Logo - Mometasone Furoate Sinus Drug Delivery Implant

Now FDA Approved

The PROPEL dissolvable steroid-releasing sinus implants are the only products backed by Level 1-A clinical evidence to improve surgical outcomes for chronic sinusitis sufferers.

PROPEL Logo - Mometasone Furoate Localized Sinus Drug Delivery

News & Press Releases